102 related articles for article (PubMed ID: 1540032)
1. Presence of paf-acether in rheumatic diseases.
Hilliquin P; Menkes CJ; Laoussadi S; Benveniste J; Arnoux B
Ann Rheum Dis; 1992 Jan; 51(1):29-31. PubMed ID: 1540032
[TBL] [Abstract][Full Text] [Related]
2. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.
Dulioust A; Hilliquin P; Menkes CJ; Benveniste J; Arnoux B
Scand J Rheumatol; 1992; 21(4):161-4. PubMed ID: 1529281
[TBL] [Abstract][Full Text] [Related]
3. PAF-acether in chronic arthritis.
Pettipher ER; Higgs GA; Henderson B
Agents Actions; 1987 Jun; 21(1-2):98-103. PubMed ID: 3630862
[TBL] [Abstract][Full Text] [Related]
4. Correlations between PAF-acether and tumor necrosis factor in rheumatoid arthritis. Influence of parenteral corticosteroids.
Hilliquin P; Houbaba H; Aissa J; Benveniste J; Menkes CJ
Scand J Rheumatol; 1995; 24(3):169-73. PubMed ID: 7777830
[TBL] [Abstract][Full Text] [Related]
5. Production of PAF-acether by synovial fluid neutrophils in rheumatoid arthritis.
Hilliquin P; Dulioust A; Gregoir C; Arnoux A; Menkés CJ
Inflamm Res; 1995 Aug; 44(8):313-6. PubMed ID: 8581516
[TBL] [Abstract][Full Text] [Related]
6. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.
Benveniste J; Roubin R; Chignard M; Jouvin-Marche E; Le Couedic JP
Agents Actions; 1982 Dec; 12(5-6):711-3. PubMed ID: 7164945
[TBL] [Abstract][Full Text] [Related]
7. Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins.
Benveniste J; Nunez D; Duriez P; Korth R; Bidault J; Fruchart JC
FEBS Lett; 1988 Jan; 226(2):371-6. PubMed ID: 3338565
[TBL] [Abstract][Full Text] [Related]
8. Variations of blood PAF-acether levels during coronary artery surgery.
Nathan N; Denizot Y; Feiss P; Laskar M; Arnoux B; Benveniste J
J Cardiothorac Vasc Anesth; 1992 Dec; 6(6):692-6. PubMed ID: 1472665
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding.
Lartigue-Mattei C; Godeneche D; Chabard JL; Petit J; Berger JA
Agents Actions; 1984 Dec; 15(5-6):643-8. PubMed ID: 6532184
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells.
Pirotzky E; Ninio E; Bidault J; Pfister A; Benveniste J
Lab Invest; 1984 Nov; 51(5):567-72. PubMed ID: 6492758
[TBL] [Abstract][Full Text] [Related]
11. Presence and metabolism of lyso platelet-activating factor in human bone marrow.
Denizot Y; Rougier F; Dupuis F; Trimoreau F; Dulery C; Laskar M; Praloran V
J Lipid Mediat Cell Signal; 1997 May; 16(1):53-62. PubMed ID: 9101422
[TBL] [Abstract][Full Text] [Related]
12. [Contamination of fermented milk products by proinflammatory autacoid paf-acether].
Denizot Y; Benveniste J
C R Acad Sci III; 1989; 309(14):593-7. PubMed ID: 2510911
[TBL] [Abstract][Full Text] [Related]
13. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
Tiberghien C; Laurent L; Junier MP; Dray F
J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
[TBL] [Abstract][Full Text] [Related]
14. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Nunez D; Russo-Marie F; Benveniste J
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists.
Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
Braz J Med Biol Res; 1987; 20(5):595-7. PubMed ID: 3452452
[TBL] [Abstract][Full Text] [Related]
17. Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis.
Eggleton P; Wang L; Penhallow J; Crawford N; Brown KA
Ann Rheum Dis; 1995 Nov; 54(11):916-23. PubMed ID: 7492242
[TBL] [Abstract][Full Text] [Related]
18. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
[TBL] [Abstract][Full Text] [Related]
19. Presence of paf-acether in human blood after thin-layer chromatography, but not after high-performance liquid chromatography purification.
Izzo AA; Benveniste J
J Pharmacol Toxicol Methods; 1996 Dec; 36(4):219-21. PubMed ID: 9040113
[TBL] [Abstract][Full Text] [Related]
20. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
